Yeast as a model for Alzheimer’s disease: Latest studies and advanced strategies

Methods in Molecular Biology

Volumn 1303, Issue , 2016, Pages 197-215

  Verduyckt, Mathias ^a   Vignaud, Hélène ^a   Bynens, Tine ^a   Van Den Brande, Jeff ^a   Franssens, Vanessa ^a   Cullin, Christophe ^a   Winderickx, Joris ^a  

^a NONE

Author keywords

Alzheimer s disease; Amyloid beta; Model; Saccharomyces; Tau; Yeast

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CALCIUM ION; GAMMA SECRETASE; HYBRID PROTEIN; PRION PROTEIN; TAU PROTEIN; PROTEIN AGGREGATE;

ALLELE; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOID PLAQUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL DEATH; CELL MATURATION; CELL MIGRATION; CELL RESPIRATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVE SITE; HEAT SHOCK RESPONSE; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OLIGOMERIZATION; OPEN READING FRAME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; RNA SPLICING; SACCHAROMYCES CEREVISIAE; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM;

EUKARYOTA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; PROTEIN AGGREGATES; SACCHAROMYCES CEREVISIAE; TAU PROTEINS;

EID: 84938675333     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2627-5_11     Document Type: Article

References (81)

1. Goffeau A, Barrell BG, Bussey H et al (1996) Life with 6000 genes. Science 274(546): 563–567
2. Suter B, Auerbach D, Stagljar I (2006) Yeastbased functional genomics and proteomics technologies: the first 15 years and beyond. Biotechniques 40:625–644
3. Christie KR, Hong EL, Cherry JM (2009) Functional annotations for the Saccharomyces cerevisiae genome: the knowns and the known unknowns. Trends Microbiol 17:286–294
4. Botstein D, Chervitz SA, Cherry JM (1997) Yeast as a model organism. Science 277: 1259–1260
5. Foury F (1997) Human genetic diseases: a cross-talk between man and yeast. Gene 195:1–10
6. Sherman F (2002) Getting started with yeast. Methods Enzymol 350:3–41
7. Winzeler EA, Shoemaker DD, Astromoff A et al (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285:901–906
8. Hu Y, Rolfs A, Bhullar B et al (2007) Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res 17: 536–543
9. Jones GM, Stalker J, Humphray S et al (2008) A systematic library for comprehensive overexpression screens in Saccharomyces cerevisiae. Nat Methods 5:239–241
10. DeRisi JL, Iyer VR, Brown PO (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680–686
11. Hoon S, St Onge RP, Giaever G et al (2008) Yeast chemical genomics and drug discovery: an update. Trends Pharmacol Sci 29:499–504
12. Parsons AB, Lopez A, Givoni IE et al (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126:611–625
13. Mager WH, Winderickx J (2005) Yeast as a model for medical and medicinal research. Trends Pharmacol Sci 26:265–273
14. Khurana V, Lindquist S (2010) Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast? Nat Rev Neurosci 11:436–449
15. Winderickx J, Delay C, De Vos A et al (2008) Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim Biophys Acta 1783:1381–1395
16. Franssens V, Bynens T, Van den Brande J et al (2013) The benefits of humanized yeast models to study Parkinson’s disease. Oxid Med Cell Longev 2013:760629
17. Zabrocki P, Pellens K, Vanhelmont T et al (2005) Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast. FEBS J 272:1386–1400
18. Swinnen E, Buttner S, Outeiro TF et al (2011) Aggresome formation and segregation of inclusions influence toxicity of alpha-synuclein and synphilin-1 in yeast. Biochem Soc Trans 39:1476–1481
19. Krobitsch S, Lindquist S (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A 97:1589–1594
20. Muchowski PJ, Schaffar G, Sittler A et al (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A 97:7841–7846
21. Meriin AB, Zhang X, He X et al (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prionlike protein Rnq 1. J Cell Biol 157:997–1004
22. Bastow EL, Gourlay CW, Tuite MF (2011) Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis. Biochem Soc Trans 39:1482–1487
23. Fu L, Sztul E (2009) ER-associated complexes (ERACs) containing aggregated cystic fibrosis transmembrane conductance regulator (CFTR) are degraded by autophagy. Eur J Cell Biol 88:215–226
24. Sergeant N, Delacourte A, Buee L (2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739:179–197
25. Esler WP, Wolfe MS (2001) A portrait of Alzheimer secretases—new features and familiar faces. Science 293:1449–1454
26. De Strooper B, Annaert W (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113: 1857–1870
27. Duce JA, Tsatsanis A, Cater MA et al (2010) Iron-export ferroxidase activity of betaamyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell 142:857–867
28. Kopan R, Ilagan MX (2004) Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5:499–504
29. Steiner H, Fluhrer R, Haass C (2008) Intramembrane proteolysis by gammasecretase. J Biol Chem 283:29627–29631
30. Turner PR, O’Connor K, Tate WP et al (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1–32
31. Ertekin-Taner N (2007) Genetics of Alzheimer’s disease: a centennial review. Neurol Clin 25:611–667
32. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509
33. Suzuki T, Araki Y, Yamamoto T et al (2006) Trafficking of Alzheimer’s disease-related membrane proteins and its participation in disease pathogenesis. J Biochem 139:949–955
34. Vetrivel KS, Thinakaran G (2006) Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 66(2 Suppl 1):S69–S73
35. Almeida CG, Takahashi RH, Gouras GK (2006) Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 26:4277–4288
36. Chen X, Yan SD (2006) Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer’s disease. IUBMB Life 58: 686–694
37. Reddy PH (2006) Amyloid precursor proteinmediated free radicals and oxidative damage: implications for the development and progression of Alzheimer’s disease. J Neurochem 96:1–13
38. Keating DJ, Chen C, Pritchard MA (2006) Alzheimer’s disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN 1. Ageing Res Rev 5:388–401
39. Scragg JL, Fearon IM, Boyle JP et al (2005) Alzheimer’s amyloid peptides mediate hypoxic up-regulation of L-type Ca 2+ channels. FASEB J 19:150–152
40. Andersen OM, Schmidt V, Spoelgen R et al (2006) Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR 11. Biochemistry 45:2618–2628
41. Zhang H, Komano H, Fuller RS et al (1994) Proteolytic processing and secretion of human beta-amyloid precursor protein in yeast. Evidence for a yeast secretase activity. J Biol Chem 269:27799–27802
42. Zhang W, Espinoza D, Hines V et al (1997) Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases. Biochim Biophys Acta 1359: 110–122
43. Luthi U, Schaerer-Brodbeck C, Tanner S et al (2003) Human beta-secretase activity in yeast detected by a novel cellular growth selection system. Biochim Biophys Acta 1620:167–178
44. Edbauer D, Winkler E, Regula JT et al (2003) Reconstitution of gamma-secretase activity. Nat Cell Biol 5:486–488
45. Sparvero LJ, Patz S, Brodsky JL et al (2007) Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast. Anal Biochem 370:162–170
46. Caine J, Sankovich S, Antony H et al (2007) Alzheimer’s Abeta fused to green fluorescent protein induces growth stress and a heat shock response. FEMS Yeast Res 7:1230–1236
47. Treusch S, Hamamichi S, Goodman JL et al (2011) Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeast. Science 334:1241–1245
48. Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41: 1088–1093
49. Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41:1094–1099
50. D’Angelo F, Vignaud H, Di Martino J et al (2013) A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Dis Model Mech 6:206–216
51. Bagriantsev S, Liebman S (2006) Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system. BMC Biol 4:32
52. Park SK, Pegan SD, Mesecar AD et al (2011) Development and validation of a yeast highthroughput screen for inhibitors of Abeta(4) (2) oligomerization. Dis Model Mech 4: 822–831
53. Buee L, Bussiere T, Buee-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95–130
54. Maas T, Eidenmuller J, Brandt R (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275:15733–15740
55. Brandt R, Leger J, Lee G (1995) Interaction of tau with the neural plasma membrane mediated by tau’s amino-terminal projection domain. J Cell Biol 131:1327–1340
56. Fulga TA, Elson-Schwab I, Khurana V et al (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9: 139–148
57. Scales TM, Derkinderen P, Leung KY et al (2011) Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn. Mol Neurodegener 6:12
58. Lee G (2005) Tau and src family tyrosine kinases. Biochim Biophys Acta 1739:323–330
59. Ittner LM, Gotz J (2011) Amyloid-beta and tau—a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci 12:65–72
60. Sergeant N, Bretteville A, Hamdane M et al (2008) Biochemistry of Tau in Alzheimer’s disease and related neurological disorders. Expert Rev Proteomics 5:207–224
61. Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4:13
62. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159
63. De Vos A, Anandhakumar J, Van den Brande J et al (2011) Yeast as a model system to study tau biology. Int J Alzheimers Dis 2011:428970
64. Vandebroek T, Vanhelmont T, Terwel D et al (2005) Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast. Biochemistry 44:11466–11475
65. Carmel G, Mager EM, Binder LI et al (1996) The structural basis of monoclonal antibody Alz50’s selectivity for Alzheimer’s disease pathology. J Biol Chem 271:32789–32795
66. Uboga NV, Price JL (2000) Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease. Neurobiol Aging 21:1–10
67. Weaver CL, Espinoza M, Kress Y et al (2000) Conformational change as one of the earliest alterations of tau in Alzheimer’s disease. Neurobiol Aging 21:719–727
68. Hallows JL, Chen K, DePinho RA et al (2003) Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J Neurosci 23:10633–10644
69. Spittaels K, Van den Haute C, Van Dorpe J et al (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155:2153–2165
70. Jicha GA, Weaver C, Lane E et al (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer’s disease. J Neurosci 19:7486–7494
71. Zheng-Fischhofer Q, Biernat J, Mandelkow EM et al (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filamentlike conformation. Eur J Biochem 252: 542–552
72. Wen Y, Planel E, Herman M et al (2008) Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci 28:2624–2632
73. Vandebroek T, Terwel D, Vanhelmont T et al (2006) Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk 5. J Biol Chem 281:25388–25397
74. Vanhelmont T, Vandebroek T, De Vos A et al (2010) Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast. FEMS Yeast Res 10:992–1005
75. Gamblin TC, Berry RW, Binder LI (2003) Tau polymerization: role of the amino terminus. Biochemistry 42:2252–2257
76. Bobba A, Petragallo VA, Marra E et al (2010) Alzheimer’s proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer’s disease. Int J Alzheimers Dis 621870, 11 pg
77. Martinez A, Portero-Otin M, Pamplona R et al (2010) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20:281–297
78. Melov S, Adlard PA, Morten K et al (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2:e536
79. Moreira PI, Santos MS, Oliveira CR et al (2008) Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7:3–10
80. Van Loon AP, Pesold-Hurt B, Schatz G (1986) A yeast mutant lacking mitochondrial manganese- superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci U S A 83:3820–3824
81. Van Dyck E, Foury F, Stillman B et al (1992) A single-stranded DNA binding protein required for mitochondrial DNA replication in S. cerevisiae is homologous to E. coli SSB. EMBO J 11:3421–3430